Four Different Experimental Drug Regimens to Standard of Care for the Treatment of Symptomatic Outpatients With COVID-19
Clinical trial NCT04532931 · COMPLETED
Trial details
- NCT number
- NCT04532931
- Sponsor
- Shin Poong Pharmaceutical Co. Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-03
- Primary completion
- 2021-08-05
- Enrollment
- 192
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.